Results 81 to 90 of about 1,254,591 (276)

Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention.

open access: yesThe Lancet Diabetes and Endocrinology, 2019
Diabetic peripheral neuropathy (DPN) is a common complication of both type 1 and 2 diabetes. It is a leading cause of lower-limb amputation and disabling neuropathic pain. Amputations in patients with diabetes have a devastating effect on quality of life
D. Selvarajah   +6 more
semanticscholar   +1 more source

Circulating Exosomes Drive Persistent Neuronal Dysfunction in Post‐Herpetic Neuralgia Patients

open access: yesAnnals of Neurology, EarlyView.
Proposed model of exosome‐mediated neuronal dysfunction in post‐herpetic neuralgia (PHN). (1) Circulating, non‐pathogenic exosomes maintain homeostatic processes in healthy skin, where sensory nerve fibers innervate the epidermis and dermis. (2) During acute zoster, reactivating varicella zoster virus (VZV) travels down neurites to the skin causing ...
Christy S. Niemeyer   +14 more
wiley   +1 more source

Correlation of vitamin D and diabetic peripheral neuropathic pain: A cross-sectional study

open access: yesJournal of International Medical Research
Objective Although ample evidence exists on the association between vitamin D deficiency and diabetic peripheral neuropathy, only a few studies have distinguished between painful and painless forms.
Caixia Yao   +9 more
doaj   +1 more source

Interconnections between diabetic corneal neuropathy and diabetic retinopathy: diagnostic and therapeutic implications

open access: yesNeural Regeneration Research
Diabetic corneal neuropathy and diabetic retinopathy are ocular complications occurring in the context of diabetes mellitus. Diabetic corneal neuropathy refers to the progressive damage of corneal nerves.
Mingyi Yu   +3 more
doaj   +1 more source

Usefulness of ratio of motor nerve conduction velocity to F-wave conduction velocity in diabetic neuropathy

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2014
Background: Diabetic poly neuropathy, a common complication of diabetes, is diagnosed by symptoms, signs, physical examination, nerve conduction studies, and other neuro-physiological methods. Although nerve conduction studies are useful in the diagnosis
Suchitra B Parkhad, Sachin B Palve
doaj   +1 more source

Physical Activity and Dietary Interventions in Diabetic Neuropathy: A Systemic Review

open access: yesClinical Autonomic Research, 2019
PurposeDiabetic neuropathy is a common and disabling disorder, and there are currently no proven effective disease-modifying treatments. Physical activity and dietary interventions in patients with diabetes and diabetic neuropathy have multiple ...
L. Zilliox, J. Russell
semanticscholar   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova   +5 more
wiley   +1 more source

A multicenter study on the prevalence of diabetic neuropathy in Italy. Italian Diabetic Neuropathy Committee.

open access: yes, 1997
The prevalence of neuropathy, a common complication of diabetes, was determined in diabetic patients recruited from 109 outpatient diabetes clinics in Italy.Neuropathy was diagnosed using the Diabetic Neuropathy Index (DNI), a standardized examination ...
P. Negrin   +11 more
core  

A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain [PDF]

open access: yes, 2014
Background: Neuropathic pain, caused by a lesion or a disease affecting the somatosensory system, is one of the most common complications in diabetic patients.
Palmer, C. N. A.; id_orcid   +21 more
core   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy